Navigation Links
Delcath to Present at the Lazard Healthcare Conference on November 15
Date:11/11/2011

esults to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to the time required to build inventory and establish commercial operations in Europe, CE Marking for the Generation Two system, the timing of our commercial launch in Europe, adoption, use and resulting sales, if any, for  CHEMOSAT in the EEA, our ability to successfully commercialize CHEMOSAT and the potential of the chemosaturation therapy as a treatment for patients with cancers in the liver, acceptability of the clinical trial data by the FDA, our ability to address the issues raised in the Refusal to File letter received from the FDA and the timing of our re-submission of our NDA, re-submission and acceptance of the Company's NDA by the FDA, approval of the Company's NDA for the treatment of metastatic melanoma to the liver, adoption, use and resulting sales, if any, in the United States, approval of the current or future Delcath system for chemosaturation in the United States and foreign markets for the same or  other indications, actions by the FDA or other foreign regulatory agencies, our ability to obtain reimbursement for CHEMOSAT, our ability to successfully enter into distribution and strategic partnership agreements in foreign markets and the corresponding revenue associated with such foreign markets, uncertainties relating to the results of research and development projects and future clinical trials, and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances
'/>"/>
SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Announces Fiscal 2011 Third Quarter Results and Recent Developments
2. Delcath Systems to Report Third Quarter Progress and Conduct Conference Call
3. FDA Schedules Delcath Pre-New Drug Application Meeting Date
4. Delcath Announces Completion of Regulatory Notification Process in New Zealand
5. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
6. Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011
7. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
8. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
9. Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
10. Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
11. Delcath Systems to Report Second Quarter Progress Update and Conduct Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... JUNCTION, N.J. , Jan. 23, 2015  CytoSorbents ... company commercializing its CytoSorb® extracorporeal cytokine adsorber to ... patients, announced the receipt of $385,642, net of ... participant of the Technology Business Tax Certificate Transfer ...
(Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/23/2015)... China , Jan. 23, 2015 Tianyin Pharmaceutical ... company that specializes in the development and sale of ... generics and active pharmaceutical ingredients (API) today announced the ... (JCM) API operation. 1. Following the September ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4
... 2, 2011 Naviscan, Inc., announces the European ... scanner at two prestigious radiology conferences in Vienna. ... Breast Imaging (EUSOBI) Annual Scientific Meeting, a podium ... Emission Mammography) data demonstrating PEM,s ability to reduce ...
... (Nasdaq: PCYC ) today announced that further ... anti-arthritis activity in mice and rats, has been suspended ... studies.  The company hopes to have a new clinical ... PCI-45292 has been under preclinical development for approximately ...
Cached Medicine Technology:Naviscan Announces European Launch of Positron Emission Mammography 2Update on Preclinical Finding and Development Timeline for PCI-45292 2Update on Preclinical Finding and Development Timeline for PCI-45292 3
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne ... highest annual revenues in the past three years. Today, the ... dresses. , According to the sales manager of the company, ... them in 2015. This point can be reflected on the ...
(Date:1/22/2015)... Payday lending practices in four southern ... financial distress to the states that permit them, according ... Center on Race and Wealth. , While they generate ... loans at the same time substantially depress economic activity, ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store ... announces its latest collection of wedding dresses , and ... issue is the wedding dress on your big day; the ... life. Every bride wants to find the most suitable wedding ...
(Date:1/22/2015)... Richmond, VA (PRWEB) January 22, 2015 ... the power at the Science Museum of Virginia. Wicked ... 24. , Wicked Plants unearths 75 poisonous, carnivorous and ... traverse through each room to uncover the biochemical, physical ...
(Date:12/26/2014)... said that nothing makes a lady feel more feminine than ... shows its new selection of navy cocktail dresses , ... navy cocktail gowns are the cornerstones of the site’s cocktail ... dresses in bright neon colors can be dressed up or ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... TeamStaff, Inc. (Nasdaq: TSTF) , a national provider of ... Company has completed an in-depth strategic review of its businesses ... and changing dynamics in the healthcare market. The analysis ... the board of directors and the executive management team led ...
... , DALLAS, Nov. 3 IBM ... of its Health Analytics Solution Center, part of a ... needed to help hospitals and medical staff improve decision-making and provide ... ) , The center will be hosted in the IBM Global ...
... Nov. 3 HealthSouth Corporation (NYSE: HLS ) today ... September 30, 2009. The results showed consolidated net operating revenues ... to $455.5 million for the third quarter of 2008, or ... a 5.3% quarter-over-quarter increase in patient discharges on both a ...
... Democratic Senators Tom Harkin and Mary Landrieu and Congresswoman ... from Des Moines, Iowa; Gwendolyn Barnes, a small business ... business owner from Richmond, Virginia; and other small business ... this morning to discuss how health insurance reform will ...
... The American Society of Hematology (ASH) is honoring two prominent ... role they play in the training and career development of ... Arthur W. Nienhuis, MD, will receive their awards during the ... who will be receiving the Mentor Award for Basic Science, ...
... Four researchers from Thomas Jefferson University have received $3.9 ... American Recovery and Reinvestment Act. The NIH has ... for this new initiative called the Challenge Grants in ... across the country have been funded. This program supports ...
Cached Medicine News:Health News:TeamStaff Announces Revised Business Strategy; Chief Executive Officer to Step Down on Completion of Search For Successor 2Health News:TeamStaff Announces Revised Business Strategy; Chief Executive Officer to Step Down on Completion of Search For Successor 3Health News:IBM Launches Health Analytics Center 2Health News:IBM Launches Health Analytics Center 3Health News:IBM Launches Health Analytics Center 4Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 2Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 3Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 4Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 5Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 6Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 7Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 8Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 9Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 10Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 11Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 12Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 13Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 14Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 15Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 16Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 17Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 18Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 19Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 20Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 21Health News:HealthSouth Reports Strong Results for Third Quarter 2009 and Increases 2009 Guidance 22Health News:Democratic Senators, Congresswoman, Small Business Owners Discuss Impact of Health Insurance Reform on Small Businesses 2Health News:Democratic Senators, Congresswoman, Small Business Owners Discuss Impact of Health Insurance Reform on Small Businesses 3Health News:The American Society of Hematology to honor inspirational hematologists with Mentor Awards 2Health News:Jefferson researchers receive $3.9 million in Challenge grants 2Health News:Jefferson researchers receive $3.9 million in Challenge grants 3
Heine Beta 200 Streak Retinoscope 2.5v...
Keeler Professional Combi Retinoscope with new slimline handle and lithium or dry cell option....
System, English (Continental cord), 230 VAC....
Micro-mini fiber optic light....
Medicine Products: